Status:

RECRUITING

Feasibility Study of Virtual Sail 3D in Cognitive Functions

Lead Sponsor:

University of Cagliari

Collaborating Sponsors:

Fondazione di Sardegna

Conditions:

Mild Cognitive Impairment

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

This research project will assess the feasibility and preliminary effectiveness of a 6-week intervention to improve cognitive functions using the 3D immersive virtual reality software "CEREBRUM" with ...

Detailed Description

Research on active aging has been identified as a priority, particularly concerning the feasibility and effectiveness of non-pharmacological interventions aimed at preventing and/or delaying cognitive...

Eligibility Criteria

Inclusion

  • Age: 65 years or older
  • Sex: all
  • Living independently,
  • Without conditions that would prevent them from participating in the activities of the experimental intervention "VSail 3D,"
  • Without severe issues with autonomous mobility
  • With Mild Cognitive Impairment (MCI) according to Addenbrooke's Cognitive Examination for cognitive functions (ACE-R), which also includes the Mini-Mental State Examination (MMSE), with the following ranges: ACE = 66.93-79.86 and/or MMSE = 21-25.
  • Signing the informed consent

Exclusion

  • severe cardiovascular conditions
  • severe issues with autonomous mobility
  • severe metabolic disorders not pharmacologically compensated
  • severe neurological conditions that prevent from participating in the experimental protocol, such as a stroke within the past 2 years, Parkinson's disease, epilepsy, or dementia (Alzheimer's, vascular, etc.)
  • severe ongoing bronchopulmonary disorders
  • severe ongoing renal disorders
  • glaucoma, retinal detachment, or other serious vision conditions that do not allow the safe use of 3D virtual reality technology
  • active malignant neoplasm that do not allow the hinders participation in the intervention.

Key Trial Info

Start Date :

May 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06579378

Start Date

May 1 2024

End Date

December 1 2025

Last Update

August 30 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Cagliari

Cagliari, CA, Italy, 09124